by Rob Garver and Charles Seife, Special to ProPublica April 15, 9:17 a.m.
In 2010, the FDA uncovered violations it later called "egregious" and "pervasive" at a major pharmaceutical testing lab. But even though the agency no longer knew for sure that drugs tested at the lab were safe, it allowed them to remain on pharmacy shelves with no new testing.